Related Experiment Video
Updated: May 8, 2025

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
Published on: December 7, 2013
Atherogenic Dyslipidemia Is Critically Related to Aortic Complicated Lesions in Cryptogenic Stroke
Muneaki Kikuno1,2, Yuji Ueno3,4, Yohei Tateishi5
1Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center.
Insights
Atherogenic dyslipidemia (AD) affects over 10% of cryptogenic stroke (CS) patients and is linked to aortic complicated lesions (ACL). Intensive lipid-modifying therapy may benefit patients with CS and AD, particularly those with ACL.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Lipidology
Background:
- Atherogenic dyslipidemia (AD), characterized by low HDL-C and high TG, is a residual risk factor for cardiovascular diseases.
- AD is associated with atheromatous thrombotic brain infarction (ATBI) and potentially cryptogenic stroke (CS).
- Aortic complicated lesions (ACL) are a significant embolic source for CS, with a risk of recurrent embolism.
Purpose of the Study:
- To investigate the association between atherogenic dyslipidemia (AD) and cryptogenic stroke (CS).
- To identify clinical features associated with AD in patients with CS.
- To explore the relationship between AD and aortic pathologies in CS patients.
Main Methods:
- Analysis of data from the CHALLENGE ESUS/CS study, including patients who underwent transesophageal echocardiography (TEE).
- Definition of AD as HDL-C ≤ 40 mg/dl and TG ≥ 150 mg/dl.
- Comparison of clinical features between patients with and without AD.
Main Results:
- 10.2% of 664 CS patients met the criteria for AD.
- Independent predictors of AD included higher body mass index, diabetes mellitus, ACL in the aortic arch, and in-hospital deterioration.
- ACL in the arch was significantly associated with AD in CS patients.
Conclusions:
- AD is prevalent in the CS population.
- AD is critically linked to ACL in patients with CS.
- Intensive lipid-modifying therapy may be beneficial for treating aortogenic brain embolism in CS patients.
Aims:
Atherogenic dyslipidemia (AD) is regarded as a residual risk of cardiovascular diseases characterized by low high-density lipoprotein cholesterol (HDL-C) and high triglyceride (TG) levels and related to the intracranial stenosis of atheromatous thrombotic brain infarction (ATBI). Further, atherosclerosis is possibly related to another stroke subtype, including cryptogenic stroke (CS). In particular, an aortic complicated lesion (ACL) is a notable embolic source of CS, since recurrence of aortogenic brain embolism is not rare. This study aimed to clarify the underlying association between AD and CS.
Methods:
CHALLENGE ESUS/CS (Mechanisms of Embolic Stroke Clarified by Transesophageal Echocardiography for ESUS/CS) had extensive data from CS patients who underwent transesophageal echocardiography (TEE). AD was defined as HDL-C ≤ 40 mg/dl and TG ≥ 150 mg/dl. Based on these criteria, patients were divided into an AD group and a non-AD group to compare the clinical features.
Results:
Of 664 CS patients (446 men, 68.7±12.8 years), 68 (10.2%) met the criteria of AD (AD group), and 596 (89.8%) were in the non-AD group. On multiple logistic regression analysis, body mass index (unit OR 1.11, 95%CI 1.04-1.19, p=0.002), diabetes mellitus (OR 2.23, 95%CI 1.28-3.87, p=0.004), ACL in the arch (OR 1.89, 95%CI 1.09-3.31, p=0.025), and deterioration during hospitalization (OR 3.96, 95%CI 1.32-10.68, p=0.009) were independently associated with AD.
Conclusion:
AD was not rare in the present CS population. Moreover, AD was crucially related to ACL in CS. Therefore, intensive and pleiotropic lipid-modifying therapy would be efficacious for further treatment of aortogenic brain embolism.
Related Concept Videos
Inflammation
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Anticoagulant Drugs: Low-Molecular-Weight Heparins

